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1. Introduction 
Starch is a natural, cheap, available, renewable, and biodegradable polymer produced 
by many plants as a source of stored energy. It is the second most abundant biomass 
material in nature. It is found in plant leaves, stems, roots, bulbs, nuts, stalks, crop 
seeds, and staple crops such as rice, corn, wheat, cassava, and potato. It has found wide 
use in the food, textiles, cosmetics, plastics, adhesives, paper, and pharmaceutical 
industries. In the food industry, starch has a wide range of applications ranging from 
being a thickener, gelling agent, to being a stabilizer for making snacks, meat products, 
fruit juices (Manek, et al., 2005). It is either used as extracted from the plant and is 
called “native starch”, or it undergoes one or more modifications to reach specific 
properties and is called “modified starch”. Worldwide, the main sources of starch are 
maize (82%), wheat (8%), potatoes (5%), and cassava (5%). In 2000, the world starch 
market was estimated to be 48.5 million tons, including native and modified starches. 
The value of the output is worth €15 billion per year (Le Corre, et al., 2010). As noted by 
Mason (2009), as far back as the first century, Celsus, a Greek physician, had described 
starch as a wholesome food. Starch was added to rye and wheat breads during the 
1890s in Germany and to beer in 1918 in England. Also, Moffett, writing in 1928, had 
described the use of corn starch in baking powders, pie fillings, sauces, jellies and 
puddings. The 1930s saw the use of starch as components of salad dressings in 
mayonnaise. Subsequently, combinations of corn and tapioca starches were used by 
salad dressing manufacturers. (Mason, 2009). Starch has also find use as sweetners; 
sweeteners produced by acid-catalyzed hydrolysis of starch were used in the 
improvement of wines in Germany in the 1830s. Between 1940 and 1995, the use of 
starch by the US food industry was reported to have increased from roughly 30 000 to 
950 000 metric tons. The leading users of starch were believed to be the brewing, baking 
powder and confectionery industries. Similar survey in Europe in 1992, showed that, 2.8 
million metric tons of starch was used in food. Several uses of starch abound in 
literature and the reader is advised to refer to more comprehensive reviews on the 
application of starch in the food industry. In fact, the versatility of starch applications is 
unparalleled as compared to other biomaterials. 
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It is obvious that, the need for starch will continue to increase especially as this biopolymer 
finds application in other industries including medicine and Pharmacy. From serving as 
food for man, starch has been found to be effective in drying up skin lesions (dermatitis), 
especially where there are watery exudates. Consequently, starch is a major component of 
dusting powders, pastes and ointments meant to provide protective and healing effect on 
skins. Starch mucilage has also performed well as emollient and major base in enemas. 
Because of its ability to form complex with iodine, starch has been used in treating iodine 
poisoning. Acute diarrhea has also been effectively prevented or treated with starch based 
solutions due to the excellent ability of starch to take up water. In Pharmacy, starch appears 
indispensable; It is used as excipients in several medicines. Its traditional role as a 
disintegrant or diluent is giving way to the more modern role as drug carrier; the 
therapeutic effect of the starch-adsorbed or starch-encapsulated or starch-conjugated drug 
largely depends on the type of starch. 
2. The role of excipients in drug delivery 
The International Pharmaceutical Excipient Council (IPEC) defines excipients as substances, 
other than the active pharmaceutical ingredient (API) in finished dosage form, which have 
been appropriately evaluated for safety and are included in a drug delivery system to either 
aid the processing or to aid manufacture, protect, support, enhance stability, bioavailability 
or patient acceptability, assist in product identification, or enhance other attributes of the 
overall safety and effectiveness of the drug delivery system during storage or use 
(Robertson, 1999). They can also be defined as additives used to convert active 
pharmaceutical ingredients into pharmaceutical dosage forms suitable for administration to 
patients. Excipients no longer maintain the initial concept of ―Inactive support; because of 
the influence they have over both biopharmaceutical aspects and technological factors 
(Jansook and Loftsson, 2009; Killen and Corrigan, 2006; Langoth, et al., 2003; Lemieux, et al., 
2009; Li, et al., 2003; Massicotte, et al., 2008; Munday and Cox, 2000; Nykänen, et al., 2001; 
Williams, et al.) The desired activity, the excipient‘s equivalent of the active ingredients 
efficacy, is called its functionality. The inherent property of an excipient is its functionality 
in the dosage form. In order to deliver a stable, uniform and effective drug product, it is 
essential to know the properties of the active pharmaceutical ingredient alone and in 
combination with all other ingredients based on the requirements of the dosage form and 
process applied. This underscores the importance of excipients in dosage form 
development. 
The ultimate application goal of any drug delivery system including nano drug delivery, is 
to develop clinically useful formulations for treating diseases in patients (Park, 2007). 
Clinical applications require approval from FDA. The pharmaceutical industry has been 
slow to utilize the new drug delivery systems if they include excipients that are not 
generally regarded as safe. This is because, going through clinical studies for FDA approval 
of a new chemical entity is a long and costly process; there is therefore, a very strong 
resistance in the industry to adding any untested materials that may require seeking 
approval. To overcome this reluctant attitude by the industry, scientists need to develop not 
only new delivery systems that are substantially better than the existing delivery systems 
(Park, 2007), but also seek for new ways of using old biomaterials. The use of starch (native 
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or modified) is an important strategy towards the attainment of this objective. This is 
because starch unlike synthetic products is biocompatible, non toxic, biodegradable, eco-
friendly and of low prices. It is generally a non-polluting renewable source for sustainable 
supply of cheaper pharmaceutical products. 
3. What is starch? 
Starch, which is the major dietary source of carbohydrates, is the most abundant storage 
polysaccharide in plants, and occurs as granules in the chloroplast of green leaves and the 
amyloplast of seeds, pulses, and tubers (Sajilata, et al., 2006). Chemically, starches are 
polysaccharides, composed of a number of monosaccharides or sugar (glucose) molecules 
linked together with ǂ-D-(1-4) and/or ǂ-D-(1-6) linkages. The starch consists of 2 main 
structural components, the amylose, which is essentially a linear polymer in which glucose 
residues are ǂ-D-(1-4) linked typically constituting 15% to 20% of starch, and amylopectin, 
which is a larger branched molecule with ǂ-D-(1-4) and ǂ-D-(1-6) linkages and is a major 
component of starch. Amylose is linear or slightly branched, has a degree of polymerization 
up to 6000, and has a molecular mass of 105 to 106 g/mol. The chains can easily form single 
or double helices. Amylopectin on the other hand has a molecular mass of 107 to 109 g/mol. 
It is highly branched and has an average degree of polymerization of 2 million, making it 
one of the largest molecules in nature. Chain lengths of 20 to 25 glucose units between 
branch points are typical. About 70% of the mass of starch granule is regarded as 
amorphous and about 30% as crystalline. The amorphous regions contain the main amount 
of amylose but also a considerable part of the amylopectin. The crystalline region consists 
primarily of the amylopectin (Sajilata, et al., 2006). 
Starch in the pharmaceutical industry 
During recent years, starch has been taken as a new potential biomaterial for pharmaceutical 
applications because of the unique physicochemical and functional characteristics (Cristina 
Freire, et al., 2009; Freire, et al., 2009; Serrero, et al.). 
3.1 Starch as pharmaceutical excipient 
Native starches were well explored as binder and disintegrant in solid dosage form, but 
due to poor flowability their utilization is restricted. Most common form of modified 
starch i.e. Pre-gelatinized starch marketed under the name of starch 1500 is now a day’s 
most preferred directly compressible excipients in pharmaceutical industry. Recently 
modified rice starch, starch acetate and acid hydrolyzed dioscorea starch were established 
as multifunctional excipient in the pharmaceutical industry. The International Joint 
Conference on Excipients rated starch among the top ten pharmaceutical ingredients 
(Shangraw, 1992). 
3.2 Starch as tablet disintegrant 
They are generally employed for immediate release tablet formulations, where drug should 
be available within short span of time to the absorptive area. Sodium carboxymethyl starch, 
which is well established and marketed as sodium starch glycolate is generally used for 
immediate release formulation. Some newer sources of starch have been modified and 
evaluated for the same. 
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3.3 Starch as controlled/sustained release polymer for drugs and hormones 
Modified starches in different forms such as Grafted, acetylated and phosphate ester 
derivative have been extensively evaluated for sustaining the release of drug for better 
patient compliances. Starch-based biodegradable polymers, in the form of microsphere or 
hydrogel, are suitable for drug delivery (Balmayor, et al., 2008), (Reis, et al., 2008). For 
example, high amylose corn starch has been reported to have good sustained release 
properties and this has been attributed to its excellent gel-forming capacity (Rahmouni, et 
al., 2003; Te Wierik, et al., 1997). Some authors (Efentakis, et al., 2007; Herman and Remon, 
1989; Michailova, et al., 2001) have explained the mechanism of drug release from such gel-
forming matrices to be a result of the controlled passage of drug molecules through the 
obstructive gel layer, gel structure and matrix. 
3.4 Starch as plasma volume expander 
Acetylated and hydroxyethyl starch are now mainly used as plasma volume expanders. 
They are mainly used for the treatment of patients suffering from trauma, heavy blood loss 
and cancer. 
3.5 Starch in bone tissue engineering 
Starch-based biodegradable bone cements can provide immediate structural support and 
degrade from the site of application. Moreover, they can be combined with bioactive 
particles, which allow new bone growth to be induced in both the interface of cement-bone 
and the volume left by polymer degradation (Boesel, et al., 2004). In addition, starch-based 
biodegradeable polymer can also be used as bone tissue engineering scaffold (Gomes, et al., 
2003). 
3.6 Starch in artificial red cells 
Starch has also been used to produce a novel and satisfactory artificial RBCs with good 
oxygen carrying capacity. It was prepared by encapsulating hemoglobin (Hb) with long-
chain fatty-acids-grafted potato starch in a self-assembly way (Xu, et al., 2011). 
3.7 Starch in nanotechnology 
Starch nanoparticles, nanospheres, and nanogels have also been applied in the construction 
of nanoscale sensors, tissues, mechanical devices, and drug delivery system. (Le Corre, et al., 
2010). 
3.7.1 Starch microparticles 
The use of biodegradable microparticles as a dosage form for the administration of active 
substances is attracting increasing interest, especially as a means of delivering proteins. 
Starch is one of the polymers that is suitable for the production of microparticles. It is 
biodegradable and has a long tradition as an excipient in drug formulations. Starch 
microparticles have been used for the nasal delivery of drugs and for the delivery of 
vaccines administered orally and intramuscularly. Bioadhesive systems based on 
polysaccharide microparticles have been reported to significantly enhance the systemic 
absorption of conventional drugs and polypeptides across the nasal mucosa, even when 
devoid of absorption enhancing agents. A major area of application of microparticles is as 
dry powder inhalations formulations for asthma and for deep-lung delivery of various 
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agents. It has also been reported that, particles reaching the lungs are phagocytosed rapidly 
by alveolar Macrophages. Although phagocytosis and sequestration of inhaled powders 
may be a problem for drug delivery to other cells comprising lung tissue, it is an advantage 
for chemotherapy of tuberculosis. Phagocytosed microparticles potentially can deliver larger 
amounts of drug to the cytosol than oral doses. It is also opined strongly that, microparticles 
have the potential for lowering dose frequency and magnitude, which is especially 
advantageous for maintaining drug concentrations and improving patient compliance. This 
is the main reason this dosage form is an attractive pulmonary drug delivery system. (Le 
Corre, et al., 2010). 
3.7.2 Starch microcapsules 
Microencapsulation is the process of enclosing a substance inside a membrane to form a 
microcapsule. it provides a simple and cost-effective way to enclose bioactive materials 
within a semi-permeable polymeric membrane. Both synthetic/semi-synthetic polymers and 
natural polymers have been extensively utilized and investigated as the preparation 
materials of microcapsules. Although the synthetic polymers display chemical stability, their 
unsatisfactory biocompatibility still limits their potential clinical applications. Because the 
natural polymers always show low/non toxicity, low immunogenicity and thereafter good 
biocompatibility, they have been the preferred polymers used in microencapsulation 
systems. Among the natural polymers, alginate is one of the most common materials used to 
form microcapsules, however, starch derivatives are now gaining attention. For instance 
starch nasal bioadhesive microspheres with significantly extended half-life have been 
reported for several therapeutic agents including insulin. Improved bioavailability of 
Gentamycin-encapsulated starch microspheres as well as magnetic starch microspheres for 
parenteral administration of magnetic iron oxides to enhance contrast in magnetic resonance 
imaging has been reported. (Le Corre, et al., 2010). 
3.7.3 Starch nanoparticles 
Nanoparticles are solid or colloidal particles consisting of macromolecular substances that 
vary in size from 10-1000 nm. The drug may be dissolved, entrapped, adsorbed, attached or 
encapsulated into the nanoparticle matrix. The matrix may be biodegradable materials such 
as polymers or proteins or biodegradable/biocompatible/bioasborbable materials such as 
starch. Depending on the method of preparation, nanoparticles can be obtained with 
different physicochemical, technical or mechanical properties as well as modulated release 
characteristics for the immobilized bioactive or therapeutic agents. (Le Corre, et al., 2010). 
4. Application of modified starches in drug delivery 
Native starch irrespective of their source are undesirable for many applications, because of 
their inability to withstand processing conditions such as extreme temperature, diverse pH, 
high shear rate, and freeze thaw variation. To overcome this, modifications are usually done 
to enhance or repress the inherent property of these native starches or to impact new 
properties to meet the requirements for specific applications. The process of starch 
modification involves the destructurisation of the semi-crystalline starch granules and the 
effective dispersion of the component polymers. In this way, the reactive sites (hydroxyl 
groups) of the amylopectin polymers become accessible to electrophilic reactants (Rajan, et 
al., 2008). Common modes of modifications useful in pharmaceuticals are chemical, physical 
www.intechopen.com
 
Scientific, Health and Social Aspects of the Food Industry 
 
360 
and enzymatic with, a much development already seen in chemical modification. Starch 
modification through chemical derivation such as etherification, esterification, cross-
linking, and grafting when used as carrier for controlled release of drugs and other 
bioactive agents. It has been shown that, chemically modified starches have more reactive 
sites to carry biologically active compounds, they become more effective biocompatible 
carriers and can easily be metabolized in the human body (Prochaska, et al., 2009; Simi 
and Emilia Abraham, 2007). 
4.1 Chemical modification of starch 
There are a number of chemical modifications made to starch to produce many different 
functional characteristics. The chemical reactivity of starch is controlled by the reactivity of 
its glucose residues. Modification is generally achieved through etherification, esterification, 
crosslinking, oxidation, cationization and grafting of starch. However, because of the dearth 
of new methods in chemical modifications, there has been a trend to combine different kinds 
of chemical treatments to create new kinds of modifications. The chemical and functional 
properties achieved following chemical modification of starch, depends largely on the 
botanical or biological source of the starch,, reaction conditions (reactant concentration, 
reaction time, pH and the presence of catalyst), type of substituent, extent of substitution 
(degree of substitution, or molar substitution), and the distribution of the substituent in the 
starch molecule (Singh, et al., 2007). Chemical modification involves the introduction of 
functional groups into the starch molecule, resulting in markedly altered physico-chemical 
properties. Such modification of native granular starches profoundly alters their 
gelatinization, pasting and retrogradation behavior (Choi and Kerr, 2003; Kim, et al., 1993) 
(Perera, et al.) and (Liu, et al., 1999) (Seow and Thevamalar, 1993). The rate and efficiency of 
the chemical modification process depends on the reagent type, botanical origin of the 
starch and on the size and structure of its granules (Huber and BeMiller, 2001).This also 
includes the surface structure of the starch granules, which encompasses the outer and inner 
surface, depending on the pores and channels (Juszczak, 2003). 
4.1.1 Carboxymethylated starch  
Starches can have a hydrogen replaced by something else, such as a carboxymethyl group, 
making carboxymethyl starch (CMS). Adding bulky functional groups like carboxymethyl 
and carboxyethyl groups reduces the tendency of the starch to recrystallize and makes the 
starch less prone to damage by heat and bacteria. Carboxymethyl starch is synthesized by 
reacting starch with monochloroacetic acid or its sodium salt after activation of the polymer 
with aqueous NaOH in a slurry of an aqueous organic solvent, mostly an alcohol. The total 
degree of substitution (DS), that is the average number of functional groups introduced in 
the polymer, mainly determines the properties of the carboxymethylated products (Heinze, 
2005). The functionalization influences the properties of the starch. For example, CMS have 
been shown to absorb an amount of water 23 times its initial weight. This high swelling 
capacity combined with a high rate of water permeation is said to be responsible for a high 
rate of tablet disintegration and drug release from CMS based tablets. CMS has also been 
reported to be capable of preventing the detrimental influence of hydrophobic lubricants 
(such as magnesium stearate) on the disintegration time of tablets or capsules.. Some of the 
recent use of carboxymethylated starch in pharmaceuticals are summarised in Table 1. 
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Table 1. Use of carboxymethylated starch in drug delivery 
4.1.2 Acetylated starch  
Acetylated starch has also been known for more than a century. Starches can be esterified by 
modifications with an acid. When starch reacts with an acid, it loses a hydroxyl group, and 
the acid loses hydrogen. An ester is the result of this reaction. Acetylation of cassava starch 
has been reported to impart two very important pharmaceutical characters to it; increased 
swelling power (Rutenberg, 1984) and enhanced water solubility of the starch granules 
(Aziz, 2004). Starch acetates and other esters can be made very efficiently on a micro scale 
without addition of catalyst or water simply by heating dry starch with acetic acid and 
anhydride at 180°C for 2-10 min (Shogren, 2003). At this temperature, starch will melt in 
acetic acid (Shogren, 2000)and thus, a homogeneous acetylation would be expected to occur. 
Using acetic acid, starch acetates are formed, which are used as film-forming polymers for 
pharmaceutical products. A much recent Scandium triflate catalyzed acetylation of starch at 
low to moderate temperatures is reported by (Shogren, 2008). Generally, starch acetates 
have a lower tendency to create gels than unmodified starch. Acetylated starches are 
distinguishable through high levels of shear strength. They are particularly stable against 
heat and acids and are equally reported to form flexible, water-soluble films. Some of the 
recent uses of acetylated starch in pharmaceuticals are summarized in Table 2. 
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Table 2. Some acetylated starches and their application in drug delivery. 
4.1.3 Hydroxypropylated starch 
Hydroxypropyl groups introduced into starch chains are said to be capable of disrupting 
inter- and intra-molecular hydrogen bonds, thereby weakening the granular structure of 
starch leading to an increase in motional freedom of starch chains in amorphous regions 
(Choi and Kerr, 2003; Seow and Thevamalar, 1993; Wootton and Manatsathit, 1983). Such 
chemical modification involving the introduction of hydrophilic groups into starch 
molecules improves the solubility of starch and the functional properties of starch pastes, 
such as its shelf life, freeze/thaw stability, cold storage stability, cold water swelling, and 
yields reduced gelatinization temperature, as well as retarded retrogradation. Owing to 
these properties, hydroxypropylated starches is gaining interest in medicine. 
 
Study Title Methodology Drug used Summary References 
Hydroxypropylated 
starches of varying 
amylose contents as 
sustained release 
matrices in tablets 
Monolithic 
matrix tablet 
formulation 
Propranolol 
hydrochloride
Hydroxypropylation 
improved the sustained 
release ability of amylose-
containing starch matrices, 
and conferred additional 
resistance to the hydrolytic 
action of pancreatin under 
simulated gastrointestinal 
conditions. 
(Onofre 
and Wang, 
2010) 
Table 3. Hydroxyl-propylated starch in drug delivery. 
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4.1.4 Succinylated starch 
Modification of starch by Succinylation has also been found to modify its physicochemical 
properties, thereby widening its applications in food and non-food industries like 
pharmaceuticals, paper and textile industries. Modification of native starch to its succinate 
derivatives reduces its gelatinisation temperature and the retrogradation, improves the 
freeze-thaw stability as well as the stability in acidic and salt containing medium (Trubiano 
Paolo, 1997; Trubiano, 1987; Tukomane and Varavinit, 2008). Generally, succinylated starch 
can be prepared by treating starches with different alkenyl succinic anhydride, for example, 
dodecenyl succinic anhydride, octadecenyl succinic anhydride or octenyl succinic 
anhydride. The incorporation of bulky octadecenyl succinic anhydride grouping to 
hydrophilic starch molecules has been found to confer surface active properties to the 
modified starch (Trubiano Paolo, 1997). Unlike typical surfactants, octadecenyl succinic 
anhydride starch, forms strong films at the oil–water interface giving emulsions that are 
resistant to reagglomeration. A recent application of succinylated starch in pharmaceuticals 
are summarized in Table 4. 
 
Study Title Methodology Drug used Summary References 
Preparation and 
characterisation of 
octenyl succinate 
starch as a delivery 
carrier for bioactive 
food components 
Pyridine-catalyzed 
esterification 
Bovine serum 
albumin/ASA
Ocetyl succcinate starch was 
found to be a potential carrier 
for colon-targeted drug 
delivery 
(Wang,  
et al., 2011) 
Table 4. A recent application of succinylated starch in drug delivery 
4.1.5 Phosphorylated starch 
Phosphorylation was the earliest method of starch modification. The reaction gives rise 
to either monostarch phosphate or distarch phosphate (cross-linked derivative), 
depending upon the reactants and subsequent reaction conditions. Phosphate cross-
linked starches show resistance to high temperature, low pH, high shear, and leads to 
increased stability of the swollen starch granule. The presence of a phosphate group in 
starch increases the hydration capacity of starch pastes after gelatinization and results 
in the correlation of the starch phosphate content to starch paste peak viscosity , 
prevents crystallization and gel-forming capacity (Nutan, et al., 2005). These new 
properties conferred on starch by phosphorylation, makes them useful as disintegrants 
in solid dosage formulations and as matrixing agents. Interestingly, it has been 
documented that, the only naturally occurring covalent modification of starch is 
phosphorylation. Traditionally, starch phosphorylation is carried out by the reaction of 
starch dispersion in water with reagents like mono- or di sodium orthophosphates, 
sodium hexametaphosphate, sodium tripolyphosphate (STPP), sodium 
trimetaphosphate (STMP) or phosphorus oxychloride. Alternative synthetic methods 
such as extrusion cooking, microwave irradiation and vacuum heating have been 
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reported (A. N. Jyothi, 2008; Sitohy and Ramadan, 2001). Some of the recent uses of 
phosphorylated starch in pharmaceuticals are summarized in Table 5. 
 
Study Title Methodology Drug used Summary References 
Starch Phosphate: 
A Novel 
Pharmaceutical 
Excipient For 
Tablet 
Formulation. 
Phosphorylation 
using mono 
sodium 
phosphate 
dehydrate 
Ziprasidone At low 
concentration, 
starch phosphate 
proved to be a 
better 
disintegrant than 
native starch in 
tablet 
formulation. 
(N.L Prasanthi, 
2010) 
Starch 
phosphates 
prepared by 
reactive extrusion 
as a sustained 
release agent. 
Reactive 
extrusion 
Metoprolol 
tartrate 
Starch phosphate 
prepared by 
reactive extrusion 
produced 
stronger 
hydrogels with 
sustained release 
properties as 
compared with 
native starch. 
(O'Brien, et al., 
2009) 
Table 5. Use of phosphorylated starch in Pharmaceuticals. 
4.1.6 Co-polymerized starch  
Chemical modification of natural polymers by grafting has received considerable attention 
in recent years because of the wide variety of monomers available. Graft copolymerization is 
considered to be one of the routes used to gain combinatorial and new properties of natural 
and synthetic polymers. In graft copolymerization the guest monomer benefits the host 
polymer with some novel and desired properties in which the resultant copolymer gains 
characteristic properties and applications (Fares, et al., 2003). As a rule, graft 
copolymerization produces derivatives of significantly increased molecular weight. Starch 
grafting usually entails etherification, acetylation, or esterification of the starch with vinyl 
monomers to introduce a reaction site for further formation of a copolymeric chain. Such a 
chain would typically consist of either identical or different vinyl monomers (block 
polymers), or it may be grafted onto another polymer altogether. Graft copolymers find 
application in the design of various stimuli-responsive controlled release systems such as 
transdermal films, buccal tablets, matrix tablets, microsphers/hydrogel bead system and 
nanoparticulate system (Sabyasachi Maiti, 2010). Some of the recent uses of graft co-
polymerized starch in pharmaceuticals is summarized in Table 6. 
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Table 6. Use of graft co-polymerized starch in Pharmaceuticals. 
4.2 Physical modification of starch 
Physical modification of starch is mainly applied to change the granular structure and 
convert native starch into cold water-soluble starch or small-crystallite starch. The major 
methods used in the preparation of cold water-soluble starches involve instantaneous 
cooking–drying of starch suspensions on heated rolls (drum-drying), puffing, continuous 
cooking–puffing–extruding, and spray-drying (Jarowrenko, 1986). A method for preparing 
granular cold water-soluble starches by injection and nozzle-spray drying was described by 
( Pitchon & Joseph 1981). Among the physical processes applied to starch modification, high 
pressure treatment of starch is considered an example of ‘minimal processing’(Stute, et al., 
1996). A process of iterated syneresis applied to the modification of potato, tapioca, corn and 
wheat starches resulted in a new type of physically modified starches (Lewandowicz and 
Soral-Smietana, 2004). Some of the recent uses of physically modified starch in 
pharmaceuticals are summarized in Table 7. 
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Table 7. Some of the recent uses of physically modified starch in medicine. 
 
Table 8. Some enzymatically modified starches and potential medical/pharmaceutical 
applications 
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4.3 Enzymatic modification of starch 
An alternative to obtaining modified starch is by using various enzymes. These include 
enzymes occurring in plants, e.g pullulanase and isoamylase groups. Pullulanase is a 1,6-ǂ-
glucosidase, which statistically impacts the linear ǂ-glucan, a pullulan which releases 
maltotriose oligomers. This enzyme also hydrolyses ǂ-1,6-glycoside bonds in amylopectin 
and dextrines when their side-chains include at least two ǂ-1,4-glycoside bonds. Isoamylase 
is an enzyme which totally hydrolises ǂ-1,6-glycoside bonds in amylopectin, glycogen, and 
some branched maltodextrins and oligosaccharides, but is characterised by low activity in 
relation to pullulan ( Norman 1981). In a study (Kim and Robyt, 1999) starch granules was 
modified in situ by using a reaction system in which glucoamylase reacts inside starch 
granules to give conversions of 10–50% D-glucose inside the granule. Enzymatic 
modification of starch still needs to be explored and studied. Some of the recent uses of 
enzymatically modified starch in pharmaceuticals is summarized in Table 8. 
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Table 9. Other starch derivatives and starch scaffolds with potential 
medical/pharmaceutical applications 
5. Conclusions 
It is obvious that starch has moved from its traditional role as food to being an 
indispensable medicine. The wide use of starch in the medicine is based on its adhesive, 
thickening, gelling, swelling and film-forming properties as well as its ready availability, 
low cost and controlled quality. From the foregoing, to think that starch is still ordinary inert 
excipients is to be oblivious of the influence this important biopolymer plays in therapeutic 
outcome of bioactive moieties. Starch has proven to be the formulator’s “friend” in that, it 
can be utilized in the preparation of various drug delivery systems with the potential to 
achieve the formulator’s desire for target or protected delivery of bioactive agents. It is 
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important to note that apart from the low cost of starch, it is also relatively pure and does 
not need intensive purification procedures like other naturally occurring biopolymers, such 
as celluloses and gums. A major limitation to starch use appears to be its higher sensitivity 
to the acid attack; however, modification has been proved to impart acid-resistance to the 
product. It is important to optimize the process of transition of starch granules from its 
native micro- to the artificial submicron levels in greater detail and also pay greater 
attention to its toxicological profiles especially when it is desired to be used at nanoscale. 
Although starch is generally regarded as safe, its derivatives and in fact at submicron levels 
it may pose some safety challenges especially as carriers in drug delivery systems. It is 
possible to conclude that, although starch is food, it is also medicine. 
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devastating, altering the environment and, ultimately, the production of foods. Experts from industry and
academia, as well as food producers, designers of food processing equipment, and corrosion practitioners
have written special chapters for this rich compendium based on their encyclopedic knowledge and practical
experience. This is a multi-authored book. The writers, who come from diverse areas of food science and
technology, enrich this volume by presenting different approaches and orientations.
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